MiR-485-3p-mediated repression of FPN may also offer a novel potential therapeutic mechanism for circumventing hepcidin-resistant mechanisms responsible for some iron overload diseases. The gene discussed is SLC40A1; the disease is Rare hereditary hemochromatosis.